Outsourced Pharma App Notes & Case Studies

91. Why Companies Are Choosing To Manufacture Biopharmaceuticals In Australia 6/21/2021

    World-class researchers, state-of-the-art facilities, a streamlined regulatory framework, and generous tax incentives have made Australia a prime location for the biotech industry.

92. Technology Selection To Enhance Bioavailability 7/23/2020

    Bioavailability challenges are among the toughest problems faced by today’s formulators. Most of the prospective drugs in pharmaceutical pipelines today have low solubility, which means the active therapeutic ingredients can’t be absorbed when patients take them orally. This paper gives an overview of obstacles to bioavailability and summarizes the Lonza technology selection process.

93. How To Accelerate Global Market Growth With Agile Product Sample Pouching Programs 4/6/2021

    A market-leading consumer health products division of a multi-national pharmaceutical company sought to grow their brand with an innovative, new vitamin product. This launch would involve complimentary sample pouches that could be distributed across a range of channels to reach as many consumers as possible. That is where Jones Healthcare Group stepped in.

94. Identifying The Decision-Makers At Your Customers’ Organizations 6/29/2021

    ISR was engaged by the Global Marketing Director at a Top 20 CDMO with the above question. The client had years of experience in marketing their brand to prospective customers but had recently begun to question the efficiency of their marketing spend. The client wanted to demonstrate to their company stakeholders that their marketing efforts were not only hitting the right targets, but that the language used in those efforts reflected their customers’ needs. Knowing this information would allow the client’s marketing department to move away from broad, product-based messaging focused on how good their services are, to messaging focused on how their services address their customers’ concerns.

95. Formulation Of Monodisperse Controlled-Release Quetiapine Microspheres 10/27/2020

    Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. The study uses technology to fabricate monodisperse quetiapine microparticles to investigate the effects of formulation and size on the release profile of the API.

96. Pluripotent Stem Cell Expansion And Scale-Up 8/5/2020

    Upstream process development is complex for stem cell therapies, because these therapies involve many manipulations during cell differentiation or even cell engineering. Decisions made early in research will impact the entire product life cycle, so it is important to consider a good process design early on.

97. Peptones: Established Supplements For Vaccine Applications 7/28/2021

    Vaccine development can be complex and expensive. Improving your development process—from cell growth to viral production—through reduced costs and increased efficiencies may, therefore, be vital for your success. Peptones can offer a solution. Rich in amino acids, peptides, vitamins, carbohydrates, nucleosides, minerals, and other components, peptones are well suited for use as supplements and feeds. To help you learn more about the potential that peptones hold, we’ve outlined four ways that peptones could benefit your vaccine development processes.

98. Spray-Dried Dispersions Enable Local Delivery For Lung Cancer 4/20/2021

    Spray drying is a leading technology for particle engineering and particularly advantageous for manufacturing particles in the inhalable range of 1-5 microns. Learn more about spray drying through two case studies of inhaled dry powders.

99. One-Step Isolation And Activation Of Naive And Early Memory T Cells With CTS Dynabeads CD3/CD28 7/6/2021

    In this application note we demonstrate nearly 100% recovery of naive and early memory T cells using Gibco™ CTS™ Dynabeads™ CD3/CD28 beads. This one-step process of simultaneous T cell isolation and activation yields pure and uniformly activated T cells.

100. Insights Into The Competitive Clinical Manufacturing Market 6/15/2020

     There are perhaps too many options when it comes to choosing the right service provider for clinical manufacturing. Drug innovators weigh in on their selection metrics and preferences as well as reveal why vendors lose bids.